In this rare condition with a prevalence of 4 per 100,000 [13], the absence of two glycosylphosphatidylinositol-anchored proteins, CD55 and CD59, leads to uncontrolled complement activation that accounts for hemolysis and the other PNH manifestations [14]. The gene discussed is CD59; the disease is paroxysmal nocturnal hemoglobinuria.